Triple

T1182959
Position Surface form Disambiguated ID Type / Status
Subject Committee for Herbal Medicinal Products E25179 entity
Predicate replaced P101 FINISHED
Object Working Party on Herbal Medicinal Products
The Working Party on Herbal Medicinal Products was a European regulatory expert group responsible for evaluating and providing guidance on the quality, safety, and efficacy of herbal medicinal products before being succeeded by the Committee for Herbal Medicinal Products.
E25179 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Working Party on Herbal Medicinal Products | Statement: [Committee for Herbal Medicinal Products, replaced, Working Party on Herbal Medicinal Products]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Working Party on Herbal Medicinal Products
Context triple: [Committee for Herbal Medicinal Products, replaced, Working Party on Herbal Medicinal Products]
  • A. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • B. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • C. Committee for Medicinal Products for Veterinary Use
    The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
  • D. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • E. Management Board of the European Medicines Agency
    The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Working Party on Herbal Medicinal Products
Triple: [Committee for Herbal Medicinal Products, replaced, Working Party on Herbal Medicinal Products]
Generated description
The Working Party on Herbal Medicinal Products was a European regulatory expert group responsible for evaluating and providing guidance on the quality, safety, and efficacy of herbal medicinal products before being succeeded by the Committee for Herbal Medicinal Products.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Working Party on Herbal Medicinal Products
Target entity description: The Working Party on Herbal Medicinal Products was a European regulatory expert group responsible for evaluating and providing guidance on the quality, safety, and efficacy of herbal medicinal products before being succeeded by the Committee for Herbal Medicinal Products.
  • A. Committee for Herbal Medicinal Products chosen
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • B. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • C. Committee for Medicinal Products for Veterinary Use
    The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
  • D. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • E. Management Board of the European Medicines Agency
    The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a494267b4c819088c97a59182bf56a completed March 1, 2026, 7:31 p.m.
NER Named-entity recognition batch_69a4bd35fb888190adf1e5d0615fa725 completed March 1, 2026, 10:27 p.m.
NED1 Entity disambiguation (via context triple) batch_69ac6f21547c81909cf23c454436e839 completed March 7, 2026, 6:32 p.m.
NEDg Description generation batch_69ac6fc5442c8190a5d824881f05d468 completed March 7, 2026, 6:34 p.m.
NED2 Entity disambiguation (via description) batch_69ac7026dda48190a72f671dba9ac17b completed March 7, 2026, 6:36 p.m.
Created at: March 1, 2026, 7:45 p.m.